Stereotaxis (STXS) FCF Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Stereotaxis (STXS) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 884.00 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 503.00 |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 646.00 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 534.00 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 919.00 |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 3,472.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 353.00 |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -97.00 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 60.00 |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | -785.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -785.00 |
| Dec 31, 2025 | -673.00 |
| Sep 30, 2025 | -2,057.00 |
| Jun 30, 2025 | -1,338.00 |
| Mar 31, 2025 | 2,345.00 |
| Dec 31, 2024 | 4,924.00 |
| Sep 30, 2024 | -3,063.00 |
| Jun 30, 2024 | -6,769.00 |
| Mar 31, 2024 | -3,017.00 |
| Dec 31, 2023 | -5,794.00 |
| Sep 30, 2023 | -698.00 |
| Jun 30, 2023 | -1,548.00 |
| Mar 31, 2023 | -1,050.00 |
| Dec 31, 2022 | -1,203.00 |
| Sep 30, 2022 | -3,074.00 |
| Jun 30, 2022 | -2,141.00 |
| Mar 31, 2022 | -2,207.00 |
| Dec 31, 2021 | -1,848.00 |
| Sep 30, 2021 | -1,077.00 |
| Jun 30, 2021 | -678.00 |